Key result
Stereotactic radioablation represents a promising noninvasive approach for ventricular tachycardia, but current mixed results and protocol heterogeneities underscore the need for randomized trials.
Answers are grounded in this paper and cite their sources.
This editorial discusses the current state, advantages, and challenges of non-invasive stereotactic radioablation for ventricular tachycardia.
The Editorial paper is related to a recently published article “Prospects for non-invasive ablation of ventricular tachycardia in patients with structural heart disease” by Korolyev S. V. and co-authors in the Journal of Arrhythmology. Current advantages and problems of stereotactic radioablation are highlighted.
No takes yet. Share an insight, caveat, or question.
А. Ш. Ревишвили (2020) conducted an editorial in Ventricular tachycardia. Stereotactic radioablation (STAR) was evaluated. Stereotactic radioablation represents a promising noninvasive approach for ventricular tachycardia, but current mixed results and protocol heterogeneities underscore the need for randomized trials.
Synapse has enriched 10 related papers. Consider them for comparative context: